Investors / China / Efung Capital
Efung Capital
Venture capital · Shenzhen, China · Asia Pacific
Efung Capital is a Chinese investment firm focused on global biopharmaceutical venture capital and private equity. Its investment team is made up of biopharmaceutical PhDs from top universities, and it has invested in companies including MicroPort, Healthgen, Frontier Biotechnologies, Ascentage Pharma, and others in China and abroad.
Invests inHealthcare & Biotech
In its own wordsbiotechpharmahealthcaremedical deviceslife sciences
Your fit with Efung Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsEfung Capital lists 35 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Seed, 33% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 79% of its companies are based in China. It invests most often alongside Decheng Capital, Qiming Venture Partners and 3E Bioventures Capital.
Counts come from funding rounds that name Efung Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Efung Capital's whole history. Rounds on record name 3 companies; its own site lists 35. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundEfung Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 33% |
| Series A | 33% |
| Series B | 0% |
| Growth | 33% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 73th | 35 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 64th | 33% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Decheng Capital | 2 |
| Qiming Venture Partners | 2 |
| 3E Bioventures Capital | 1 |
| Bay City Capital | 1 |
| BiomedVC | 1 |
| Catalio Capital Management | 1 |
| Clal Biotechnology Industries | 1 |
| HSG | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3394%
- No longer answers00%
- Points to another company26%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Efung Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Efung Capital| Date | Company | Stage |
|---|---|---|
| 15 Jan 2026 | Series A |
Round details for Efung Capital
Amounts, full round histories and every co-investor in Efung Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
35 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| ACM Biolabs is a clinical-stage biotechnology company that develops new medicines using its proprietary thermostable polymer-based nanoparticle delivery platform | Healthcare & Biotech | Portfolio page | ||
| Aleva Neurotherapeutics has developed a high resolution neurostimulation platform that delivers therapy with high selectivity. | Healthcare & Biotech | Portfolio page | ||
| Alioth Biotech develops and applies pharmaceutical process filtration products and technologies, providing separation and purification solutions for pharmaceutical companies. | Healthcare & Biotech | Jan 2026Series A | Funding round | |
Healthcare & Biotech | Portfolio page | |||
| Ascentage Pharma is a biopharmaceutical company that develops innovative drugs, particularly in the field of oncology | Healthcare & Biotech | Portfolio page | ||
| Asieris Pharmaceuticals focuses on the fields of urological tumors and women's health, including breast cancer and gynecological tumors. | Healthcare & Biotech | Portfolio page | ||
| The company develops and tests immune-modulating therapies for cancer treatment. | Healthcare & Biotech | Portfolio page | ||
| The company develops and commercializes new anti-tumor drugs using synthetic biology technology. | Healthcare & Biotech | Portfolio page | ||
| CATUG provides contract research, development, and manufacturing services for advanced therapies, including nucleic acid and cell therapies. | Healthcare & Biotech | Portfolio page | ||
| Centrexion Therapeutics is a dynamic company that develops drugs for non-opioid pain relief and immunology | Healthcare & Biotech | Portfolio page | ||
| The company develops and produces high-end innovative medical devices, including artificial hearts and mechanical circulatory support devices. | Healthcare & Biotech | Portfolio page | ||
| Elicio Therapeutics engineers cancer immunotherapies that harness the natural power of the immune system | Healthcare & Biotech | Portfolio page | ||
| The company develops and manufactures pharmaceutical products, including treatments for COVID-19 and HIV. | Healthcare & Biotech | Portfolio page | ||
| The company develops and researches various biotech products, including molecular glue degraders and innovative drugs. | Healthcare & Biotech | Portfolio page | ||
| HaploX provides genetic detection and medical services, including tumor and health management products | Healthcare & Biotech | Portfolio page | ||
| Gaoguang Pharmaceutical is a clinical-stage biopharmaceutical company focused on autoimmune/inflammatory diseases of the peripheral and central nervous system | Healthcare & Biotech | Portfolio page | ||
| Insight Lifetech is a medtech company dedicated to developing innovative solutions with the potential to transform precision diagnosis and treatment of cardiovascular diseases. | Healthcare & Biotech | Portfolio page | ||
| The company develops and produces capsule endoscopy systems for gastrointestinal screening | Healthcare & Biotech | Portfolio page | ||
| The company develops and manufactures pharmaceutical products, focusing on auxiliary reproduction and ophthalmology fields. | Healthcare & Biotech | Portfolio page | ||
| KBP is a world-class biotechnology research and development organization dedicated to providing innovative therapies for unmet medical needs | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- efungcapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 15 Jan 2026
- Companies checked
- 35
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Efung Capital's profile as data
Pull Efung Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/efungcapital.com
# also
GET /v1/firms/efungcapital.com/portfolio
GET /v1/firms/efungcapital.com/coinvestors
GET /v1/firms/efungcapital.com/news